Adenoidectomy for otitis media with effusion.
The efficacy of adenoidectomy in the surgical treatment of children with otitis media with effusion (OME) persisting after adequate medical therapy has been established in three independent randomized clinical trials. Although each of these studies used a different experimental design, all showed significant reductions in morbidity from OME after adenoidectomy as compared to the control groups. Subsequent application of these findings in formulating clinical guidelines for the use of adenoidectomy has yet to be realized, and recommendations to parents for or against the procedure appear to vary more with the surgeon's philosophy than with the condition of the child. This discussion examines the effectiveness and cost of adenoidectomy for the treatment of children with chronic OME and addresses the question of whether adenoidectomy should be used as a primary or a secondary surgical therapy. The argument is made to use adenoidectomy as a primary therapy in selected cases on the basis of patient age, type of OME, and patient preference, and to base the decision not on the size of the adenoid, but on its known pathophysiology.
Gates
G A
GA
Virginia Merrill Bloedel Hearing Research Center, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle 98195.
D000233:Adenoidectomy / Q000379:methods*; D000234:Adenoids / Q000473:pathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D007758:Ear, Inner / Q000503:physiopathology; D004432:Ear, Middle / Q000473:pathology; D005064:Eustachian Tube / Q000503:physiopathology; D006801:Humans; D006984:Hypertrophy; D007223:Infant; D007231:Infant, Newborn; D010034:Otitis Media with Effusion / Q000503:physiopathology / Q000601:surgery*